B. Frieberg - Jun 30, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg
Stock symbol
VCNX
Transactions as of
Jun 30, 2023
Transactions value $
$17,433
Form type
4
Date filed
10/5/2023, 04:30 PM
Previous filing
May 15, 2023
Next filing
Oct 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 4.24K Jun 30, 2023 Direct
holding VCNX Common Stock 6.3K Jun 30, 2023 By Benbow Estates, Ltd. F1
holding VCNX Common Stock 12.9K Jun 30, 2023 By Gee Eff Services Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $8.74K +2.41K $3.62 2.41K Jun 30, 2023 Common Stock 2.41K $5.34 Direct F9
transaction VCNX Stock Option (Right to Buy) Award $8.69K +11.3K $0.77 11.3K Sep 29, 2023 Common Stock 11.3K $1.13 Direct F10
holding VCNX Stock Option (Right to Buy) 6.4K Jun 30, 2023 Common Stock 6.4K $204.00 Direct F3
holding VCNX Stock Option (Right to Buy) 2.5K Jun 30, 2023 Common Stock 2.5K $78.90 Direct F3
holding VCNX Stock Option (Right to Buy) 7.72K Jun 30, 2023 Common Stock 7.72K $116.70 Direct F3, F4
holding VCNX Stock Option (Right to Buy) 2.39K Jun 30, 2023 Common Stock 2.39K $82.80 Direct F3
holding VCNX Stock Option (Right to Buy) 1.86K Jun 30, 2023 Common Stock 1.86K $107.55 Direct F3
holding VCNX Stock Option (Right to Buy) 2.74K Jun 30, 2023 Common Stock 2.74K $72.75 Direct F3
holding VCNX Stock Option (Right to Buy) 3.34K Jun 30, 2023 Common Stock 3.34K $60.00 Direct F3
holding VCNX Stock Option (Right to Buy) 15.7K Jun 30, 2023 Common Stock 15.7K $59.25 Direct F3, F5
holding VCNX Stock Option (Right to Buy) 3.76K Jun 30, 2023 Common Stock 3.76K $54.15 Direct F3
holding VCNX Stock Option (Right to Buy) 7.63K Jun 30, 2023 Common Stock 7.63K $26.70 Direct F3
holding VCNX Stock Option (Right to Buy) 6.55K Jun 30, 2023 Common Stock 6.55K $31.05 Direct F3
holding VCNX Stock Option (Right to Buy) 4.54K Jun 30, 2023 Common Stock 4.54K $44.70 Direct F3
holding VCNX Stock Option (Right to Buy) 28.6K Jun 30, 2023 Common Stock 28.6K $32.25 Direct F3, F6
holding VCNX Stock Option (Right to Buy) 4.8K Jun 30, 2023 Common Stock 4.8K $42.00 Direct F3
holding VCNX Stock Option (Right to Buy) 6.23K Jun 30, 2023 Common Stock 6.23K $32.40 Direct F3
holding VCNX Stock Option (Right to Buy) 12.9K Jun 30, 2023 Common Stock 12.9K $15.60 Direct F3
holding VCNX Stock Option (Right to Buy) 10K Jun 30, 2023 Common Stock 10K $19.80 Direct F3
holding VCNX Stock Option (Right to Buy) 53.3K Jun 30, 2023 Common Stock 53.3K $16.80 Direct F3, F7
holding VCNX Stock Option (Right to Buy) 12.1K Jun 30, 2023 Common Stock 12.1K $16.20 Direct F3
holding VCNX Stock Option (Right to Buy) 26.3K Jun 30, 2023 Common Stock 26.3K $7.43 Direct F3
holding VCNX Stock Option (Right to Buy) 19.9K Jun 30, 2023 Common Stock 19.9K $9.68 Direct F3
holding VCNX Stock Option (Right to Buy) 32.1K Jun 30, 2023 Common Stock 32.1K $5.99 Direct F3
holding VCNX Stock Option (Right to Buy) 144K Jun 30, 2023 Common Stock 144K $6.15 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
F3 Exercisable in full as of the date of this report.
F4 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F7 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F8 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F9 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
F10 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Remarks:

On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). All figures in this Form 4 reflect the Reverse Stock Split.